W P Peters - JoVE Visualize

Showing results (31-40 of 103) with videos related to

Pageof 11

Sort By:

Ophthalmology|January 1, 1996

Retinopathy and optic neuropathy in bone marrow transplantation for breast cancerJ A Khawly, P Rubin, W Petros, et al.

Blood|October 1, 1988

Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humansW P Peters, A Stuart, M L Affronti, et al.

Bone Marrow Transplantation|August 1, 1994

Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow supportB Meisenberg, M Lassiter, A Hussein, et al.

Bone Marrow Transplantation|February 1, 1995

Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicityT Murase, M S Anscher, W P Petros, et al.

Intervirology|January 1, 1978

Contrasting characteristics of Marek's disease herpesvirus isolated from chickens with and without avian leukosis virus infectionW F Campbell, D W Kufe, W P Peters, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996

Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic techniqueC L Tyer, J J Vredenburgh, M Heimer, et al.

The New England Journal of Medicine|June 3, 1993

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancerM S Anscher, W P Peters, H Reisenbichler, et al.

Transplantation|July 1, 1988

Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow supportG A Olsen, J P Gockerman, R C Bast, et al.

Blood|April 1, 1993

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapyW P Peters, G Rosner, M Ross, et al.

The American Review of Respiratory Disease|May 1, 1993

Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantationN W Todd, W P Peters, A H Ost, et al.

Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:

Pageof 11

Ophthalmology|January 1, 1996

Retinopathy and optic neuropathy in bone marrow transplantation for breast cancerJ A Khawly, P Rubin, W Petros, et al.

Blood|October 1, 1988

Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humansW P Peters, A Stuart, M L Affronti, et al.

Bone Marrow Transplantation|August 1, 1994

Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow supportB Meisenberg, M Lassiter, A Hussein, et al.

Bone Marrow Transplantation|February 1, 1995

Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicityT Murase, M S Anscher, W P Petros, et al.

Intervirology|January 1, 1978

Contrasting characteristics of Marek's disease herpesvirus isolated from chickens with and without avian leukosis virus infectionW F Campbell, D W Kufe, W P Peters, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996

Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic techniqueC L Tyer, J J Vredenburgh, M Heimer, et al.

The New England Journal of Medicine|June 3, 1993

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancerM S Anscher, W P Peters, H Reisenbichler, et al.

Transplantation|July 1, 1988

Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow supportG A Olsen, J P Gockerman, R C Bast, et al.

Blood|April 1, 1993

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapyW P Peters, G Rosner, M Ross, et al.

The American Review of Respiratory Disease|May 1, 1993

Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantationN W Todd, W P Peters, A H Ost, et al.

Pageof 11